Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 05 - 05 tags : Earnings save search
Kala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-05-05 (Crawled : 13:00) - biospace.com/
MS | News 0 d | $93.85 0.1% -0.02% 3.3M
|
Finance
|
| O: 0.33%
H: 2.33%
C: 1.93%
KALA | $6.4 -2.53% 4.24% 1.1K
|
Health Technology
|
| O: 0.0%
H: 0.93%
C: -7.75%
financial results results
Bruker Reports First Quarter 2021 Financial Results
Published: 2021-05-05 (Crawled : 13:00) - biospace.com/
BRKR | $82.2 -0.32% -0.3% 990K
|
Health Technology
|
| O: 4.0%
H: 0.0%
C: -3.18%
financial results results report
Vericel Reports First Quarter 2021 Financial Results and Raises Full-Year 2021 Revenue Guidance
Published: 2021-05-05 (Crawled : 13:00) - biospace.com/
VCEL | $46.11 -0.67% -0.72% 200K
|
Health Technology
|
| O: -4.24%
H: 3.25%
C: -0.09%
MDWD | $17.59 7.19% 6.44% 47K
|
Health Technology
|
| O: 1.71%
H: 0.42%
C: -11.13%
financial results results ev
Establishment Labs Reports Record First Quarter 2021 Financial Results and Raises Full Year Guidance
Published: 2021-05-05 (Crawled : 13:00) - biospace.com/
ESTA | $48.95 -1.49% -1.58% 160K
|
Health Technology
|
| O: 3.69%
H: 0.1%
C: -1.06%
financial results results
Clovis Oncology Announces First Quarter 2021 Operating Results
Published: 2021-05-05 (Crawled : 13:00) - biospace.com/
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: -4.17%
H: 20.45%
C: 10.98%
results
NeoGenomics Reports 9% Revenue Growth to $116 Million in the First Quarter
Published: 2021-05-05 (Crawled : 12:00) - biospace.com/
NEO | $14.03 -0.92% -0.93% 540K
|
Health Services
|
| O: -2.5%
H: 5.28%
C: -9.55%
genomic growth
InMode Reports First Quarter 2021 Financial Results: Quarterly Revenues of $65.5 Million Represent 62% Year over Year Growth. GAAP Earnings per Share of $0.63, 320% Year over Year Growth
Published: 2021-05-05 (Crawled : 12:00) - biospace.com/
INMD | $17.36 -0.06% -0.06% 700K
|
Health Technology
|
| O: 1.58%
H: 0.52%
C: -5.01%
financial results results growth
Horizon Therapeutics plc Reports First-Quarter 2021 Financial Results; Updating Full-Year 2021 Net Sales Guidance and Full-Year Adjusted EBITDA Guidance to Incorporate Recently Acquired Viela Bio, Inc.
Published: 2021-05-05 (Crawled : 12:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: -1.63%
H: 3.01%
C: 0.06%
sales financial results acquired dating results
LENSAR Reports First Quarter 2021 Financial Results and Provides Business Update
Published: 2021-05-05 (Crawled : 12:00) - biospace.com/
LNSR | $3.26 2.52% 0.31% 8.3K
|
Health Technology
|
| O: 0.84%
H: 1.24%
C: -1.66%
financial results results
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
RILY | $29.75 36.97% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.